Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs) — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(2 sites)
United States
Mayo Clinic - Rochester, Rochester, Minnesota Washington University School of Medicine, St Louis, Missouri Last updated December 2025